CIAM
EWTX icon

Caitong International Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Caitong International Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.45K Sell
208
-4,070
-95% -$140K ﹤0.01% 1197
2026
Q1 		$135K Buy
4,278
+3,568
+503% +$103K 0.02% 499
2025
Q4 		$17.6K Buy
+710
New +$14.3K ﹤0.01% 1023
2025
Q2 		– Sell
-3,194
Closed -$70.3K – 2145
2025
Q1 		$70.3K Buy
3,194
+1,141
+56% +$29.9K 0.05% 380
2024
Q4 		$54.8K Buy
+2,053
New +$65.4K 0.05% 446

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caitong International Asset Management's EWTX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Edgewise Therapeutics (EWTX) stake by 95% in Q2 2026, selling an estimated $140K and leaving 208 shares worth $8.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Caitong International Asset Management first reported a position in EWTX in Q4 2024 and has held it in 5 quarters since. The position peaked at $135K in Q1 2026. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Caitong International Asset Management held 208 shares of Edgewise Therapeutics worth $8.45K as of Q2 2026.
  • Caitong International Asset Management sold 4,070 Edgewise Therapeutics shares in Q2 2026, an estimated $140K.
  • Edgewise Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1197 holding.
  • Caitong International Asset Management first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Edgewise Therapeutics position peaked at $135K in Q1 2026.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.